真性红细胞增多症的所有病例中均存在JAK2突变。 - Suppr

Suppr

超能文献

JAK2 Mutations are present in all cases of polycythemia vera.

作者信息

Wang Y L, Vandris K, Jones A, Cross N C P, Christos P, Adriano F, Silver R T

出版信息

Leukemia. 2008 Jun;22(6):1289. doi: 10.1038/sj.leu.2405047. Epub 2007 Dec 13.

DOI:10.1038/sj.leu.2405047

PMID:18079740

Abstract

摘要

相似文献

JAK2 Mutations are present in all cases of polycythemia vera.真性红细胞增多症的所有病例中均存在JAK2突变。

Leukemia. 2008 Jun;22(6):1289. doi: 10.1038/sj.leu.2405047. Epub 2007 Dec 13.

JAK2 V617F/C618R mutation in a patient with polycythemia vera: a case study and review of the literature.真性红细胞增多症患者的JAK2 V617F/C618R突变：病例报告及文献综述

Cancer Genet Cytogenet. 2009 Feb;189(1):43-7. doi: 10.1016/j.cancergencyto.2008.09.010.

Detection of a new JAK2 D620E mutation in addition to V617F in a patient with polycythemia vera.在一名真性红细胞增多症患者中，除检测到JAK2 V617F突变外，还发现了一种新的JAK2 D620E突变。

Leukemia. 2006 Dec;20(12):2210-1. doi: 10.1038/sj.leu.2404419. Epub 2006 Sep 28.

JAK2 mutations other than V617F: a novel mutation and mini review.除V617F之外的JAK2突变：一种新突变及小型综述

Leuk Res. 2008 Feb;32(2):365-6. doi: 10.1016/j.leukres.2007.02.018. Epub 2007 Apr 26.

Frequency of Janus associated kinase 2 (V617F) mutation in patients of polycythemia vera.真性红细胞增多症患者中Janus相关激酶2（V617F）突变的频率

J Coll Physicians Surg Pak. 2012 Feb;22(2):80-3.

[Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].慢性骨髓增殖性疾病诊断的新方法——JAK2 突变检测

Orv Hetil. 2006 Nov 12;147(45):2175-9.

Mutations in exon 12 of JAK2 are mainly found in JAK2 V617F-negative polycythaemia vera patients.JAK2基因第12外显子的突变主要见于JAK2 V617F阴性的真性红细胞增多症患者。

Br J Haematol. 2008 Aug;142(4):676-9. doi: 10.1111/j.1365-2141.2008.07223.x. Epub 2008 May 22.

JAK2 V617F positive polycythemia Vera in a child with neurofibromatosis type I.一名患有Ⅰ型神经纤维瘤病的儿童的JAK2 V617F阳性真性红细胞增多症。

Pediatr Blood Cancer. 2008 Nov;51(5):689-91. doi: 10.1002/pbc.21659.

JAK2 mutations in polycythemia vera--molecular mechanisms and clinical applications.真性红细胞增多症中的JAK2突变——分子机制与临床应用

N Engl J Med. 2007 Feb 1;356(5):444-5. doi: 10.1056/NEJMp068293.

JAK2 exon 12 mutations in polycythemia vera or idiopathic erythrocytosis.真性红细胞增多症或特发性红细胞增多症中的JAK2外显子12突变。

Haematologica. 2007 Dec;92(12):1717-8. doi: 10.3324/haematol.12011.

引用本文的文献

The development of polycythemia vera after phlebotomy treatment for hereditary haemochromatosis.遗传性血色素沉着症放血治疗后真性红细胞增多症的发展。

EJHaem. 2021 May 21;2(3):537-538. doi: 10.1002/jha2.222. eCollection 2021 Aug.

CRISPR/Cas12a-Based Ultrasensitive and Rapid Detection of V617F Somatic Mutation in Myeloproliferative Neoplasms.基于 CRISPR/Cas12a 的超灵敏快速检测骨髓增殖性肿瘤中的 V617F 体细胞突变。

Biosensors (Basel). 2021 Jul 24;11(8):247. doi: 10.3390/bios11080247.

Phenotypical differences and thrombosis rates in secondary erythrocytosis versus polycythemia vera.继发性红细胞增多症与真性红细胞增多症的表型差异及血栓形成率

Blood Cancer J. 2021 Apr 15;11(4):75. doi: 10.1038/s41408-021-00463-x.

JAK2S523L, a novel gain-of-function mutation in a critical autoregulatory residue in JAK2V617F- MPNs.JAK2S523L，一种在JAK2V617F-骨髓增殖性肿瘤关键自调控残基上的新型功能获得性突变。

Blood Adv. 2020 Sep 22;4(18):4554-4559. doi: 10.1182/bloodadvances.2019001283.

Erythrocytosis caused by giant chromophobe renal cell carcinoma: a case report indicating a 9-year misdiagnosis of polycythemia vera.巨大嫌色肾细胞癌所致红细胞增多症：一例提示真性红细胞增多症误诊9年的病例报告

Chin J Cancer. 2017 Sep 6;36(1):72. doi: 10.1186/s40880-017-0238-z.

The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study.低JAK2V617F等位基因负荷在临床实践中的相关性：一项单中心研究。

Oncotarget. 2017 Jun 6;8(23):37239-37249. doi: 10.18632/oncotarget.16744.

JAK2V617F allele burden is reduced by busulfan therapy: a new observation using an old drug.白消安治疗可降低JAK2V617F等位基因负荷：一种旧药的新观察结果

Haematologica. 2013 Nov;98(11):e135-7. doi: 10.3324/haematol.2013.087742.

Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study.建立最佳的定量聚合酶链反应检测方法，用于 JAK2-V617F 相关骨髓增殖性肿瘤的常规诊断和微小残留病监测：一项欧洲白血病网络/MPN&MPNr-EuroNet（COST 行动 BM0902）联合研究。

Leukemia. 2013 Oct;27(10):2032-9. doi: 10.1038/leu.2013.219. Epub 2013 Jul 17.

Update on JAK2 Inhibitors in Myeloproliferative Neoplasm.骨髓增殖性肿瘤中 JAK2 抑制剂的最新进展。

Ther Adv Hematol. 2011 Apr;2(2):61-71. doi: 10.1177/2040620711401646.

When the Brakes are Lost: LNK Dysfunction in Mice, Men, and Myeloproliferative Neoplasms.当刹车失灵时：LNK 功能障碍在小鼠、男性和骨髓增殖性肿瘤中的作用。

Ther Adv Hematol. 2011 Feb;2(1):11-9. doi: 10.1177/2040620710393391.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验